Business Wire

NetApp Powers Porsche Motorsport to ABB FIA Formula E World Championship Wins with Data-driven Cloud Solutions

13.7.2022 15:00:00 EEST | Business Wire | Press release

Share

NetApp® (NASDAQ: NTAP), a global cloud-led, data-centric software company, and TAG Heuer Porsche Formula E Team, today announced a multi-year partnership. NetApp will provide the sportscar maker with innovative hybrid cloud solutions that will help them continue to write car racing history.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220713005218/en/

Porsche AG, a global automotive brand owned by Volkswagen Group, has begun shifting production towards electric or e-fuel powered vehicles in 2015. By the year 2030, Porsche AG aims for 80% of all vehicles sold to be electric. Tapping into NetApp’s real-time data services, TAG Heuer Porsche Formula E Team helps deliver on the vision of sustainable mobility while enabling the real-time adjustments that deliver superior race performance – and help drive the next generation of Porsche electric vehicles.

Real-time data collaboration service for the racetrack

NetApp's hybrid cloud solutions enable TAG Heuer Porsche Formula E Team to access their data trackside to support driver and team performance. This helps them make data-driven decisions in real-time, for example when to use the Formula E Attack Mode, which unlocks an additional 30 kilowatts of engine power. The rules about engaging Attack Mode are set by FIA shortly before every ePrix, hence it has a great impact on race strategy.

With data at the core of racing, business, and engineering decisions, the TAG Heuer Porsche Formula E Team requires cutting-edge data management technology:

  • Data and systems need to be available at the racetrack and fulfill demanding performance requirements.
  • Digital data collected during the ePrix must be uploaded to the cloud for analysis while the race is still running.
  • Cloud data needs to be processed by the team at Porsche Motorsport headquarters in Weissach, Germany for R&D.
  • After the race, data must be transferred to the cloud so it can be utilized in the future, and to support crucial data services such as backup and archiving.

The hybrid cloud data solution designed by NetApp and Porsche in response combines cloud network-attached (NAS) storage services with Global File Cache to ensure data can flow seamlessly and quickly between different widely dispersed locations. It also integrates powerful NetApp data services to ensure version consistency, manage and monitor cloud resources, and protect Porsche’s intellectual property:

  • Cloud Volumes ONTAP is the primary storage platform for TAG Heuer Porsche Formula E Team. The multicloud solution deployed on Azure acts as a hub that consolidates all the team’s data.
  • Global File Cache, the cloud volume edge capability provides local edge instances, enabling low-latency access to a common dataset, both at the on-premises development center in Weissach and the racetrack.
  • Cloud Manager delivers centralized orchestration across hybrid cloud storage infrastructure and all data management services, so that TAG Heuer Porsche Formula E Team can manage, monitor and automate all their data software and hardware consumption.
  • Cloud Backup integrates as backup and archive layer for the consolidated cloud data.

“Formula E is a technology showcase and R&D backbone for Porsche and preserves our strong motorsports heritage on the road and on the track,” said Friedemann Kurz, Head of Motorsport IT, Porsche. “Data is the defining element here, but it is not easy to harness when the racing team is always on the road. The solution created by NetApp is unique in the market in how it can move huge amounts of data at high speed while delivering an intuitive experience across edge, core and cloud so we can design better, faster cars for our racecar drivers and car enthusiasts everywhere.”

“This is a winning partnership in which two champions meet eye-to-eye. Porsche has secured over 30,000 wins in all major car racing series. NetApp has submitted more than 2,500 data innovation patents. Joining forces now, we are working to make our mark on the future of racing,” said James Whitemore, Executive Vice President and Chief Marketing Officer at NetApp. “Digital data is collected by the cars’ many sensors as they dart along the track and is processed synchronously to predict outcomes to aid the trackside team. Data equals speed.”

Additional Resources

About NetApp

NetApp is a global, cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter, LinkedIn, Facebook, and Instagram.

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc.

About Porsche in Formula E

With the Porsche 99X Electric, Porsche returned to open-wheel single-seater racing in 2019 after more than 30 years and celebrated a successful debut scoring second place at the season-opener in Saudi Arabia’s Diriyah in the ABB Formula E season 6. In 2021/2022, the TAG Heuer Porsche Formula E Team contests its third Formula E season with the Porsche 99X Electric – and clinched an historic one-two result in Mexico on 12 February 2022. The fully electric racing car sporting the Weissach-developed Porsche E Performance Powertrain also serves as a development platform for the sports car manufacturer’s fully electric production models. Energy management and efficiency are important factors of success in Formula E and in the development of production cars. For the 2021/2022 season, the 99X Electric has a maximum output of 250 kW in qualification mode and 220 kW (last season 200 kW) in normal race mode. Attack Mode boosts the output to 250 kW (last season 235 kW). Maximum recuperation is 250 kW; the usable battery capacity is 52 Kilowatt-hours.

Formula E is the Fédération Internationale de l'Automobile’s (FIA) innovative and sustainable international championship for electric open-wheel racing cars.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contacts:
Kenya Hayes
NetApp
kenya.hayes@netapp.com

Marvin Sauer
NetApp
marvin.sauer@netapp.com

Viktoria Wohlrapp
Porsche
viktoria.wohlrapp@porsche.de

Investor Contact:
Lance Berger
NetApp
lance.berger@netapp.com

About Business Wire

Business Wire
Business Wire



http://www.businesswire.com

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye